China Universal Asset Management Co., Ltd. Immunity Bio, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $893 Million
- Q3 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Immunity Bio, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 133,966 shares of IBRX stock, worth $350,990. This represents 0.06% of its overall portfolio holdings.
Number of Shares
133,966
Previous 81,250
64.88%
Holding current value
$350,990
Previous $513,000
3.12%
% of portfolio
0.06%
Previous 0.07%
Shares
14 transactions
Others Institutions Holding IBRX
# of Institutions
204Shares Held
70MCall Options Held
1.68MPut Options Held
1.31M-
Vanguard Group Inc Valley Forge, PA16.9MShares$44.3 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$29.9 Million0.0% of portfolio
-
State Street Corp Boston, MA8.65MShares$22.7 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.85MShares$10.1 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.25MShares$5.89 Million0.0% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $1.05B
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...